If the findings described here in yeast are verified in mammalian cells, drugs that prevent TDP-43 from inhibiting TOROID formation may prove therapeutic for a variety of neurodegenerative diseases characterized by TDP-43 aggregation. This evidence concerns the gene TARDBP and neurodegenerative disease.